↑

Announcement of Exhibiting at ITEM2026 International Technical Exhibition of Medical Imaging and Hosting a Co-sponsored Seminar at the 85th Annual Meeting of the Japan Radiological Society

AiRato Inc. will exhibit at the ITEM2026 International Technical Exhibition of Medical Imaging, to be held in April 2026.

Exhibition Overview

  • Exhibition Name: ITEM2026 International Technical Exhibition of Medical Imaging
  • Dates & Times:
    • Friday, April 17, 2026 | 10:00–18:00
    • Saturday, April 18, 2026 | 09:30–18:00
    • Sunday, April 19, 2026 | 09:00–12:00
  • Venue: Pacifico Yokohama (1-1-1 Minato Mirai, Nishi-ku, Yokohama, Kanagawa, Japan)
  • Exhibit Content: AI-assisted radiation therapy treatment planning software

Co-sponsored Seminar Overview

We will also host a co-sponsored seminar at the 85th Annual Meeting of the Japan Radiological Society under the theme:“The Forefront of AI in Radiation Therapy — Exploring the Present and Future of Automation through Insights from Malaysia and Japan.”

85th Annual Meeting of the Japan Radiological Society

  • Date & Time: Thursday, April 16, 2026 | 12:00–12:50
  • Venue: Rooms 313+314, Pacifico Yokohama
  • Address: 1-1-1 Minato Mirai, Nishi-ku, Yokohama, Kanagawa, Japan
  • Speakers:
  • Chair:Prof. Keiichi Jingu
    • Department of Radiation Oncology, Tohoku University Graduate School of Medicine
  • Speaker 1 :Associate Prof Rei Umezawa
    • Associate Professor, Department of Radiation Oncology,Tohoku University Graduate School of Medicine
    • Theme: AI Segmentation from a Clinician’s Perspective: Challenges Toward Workflow Optimization
  • Speaker 2:Zulaikha Jamalludin, PhD
    • Clinical Oncology Physicist/Senior Lecturer Dept. of Clinical Oncology, University Malaya Medical Center
    • Theme: Feasibility Study and Evaluation of AI-assisted Treatment Planning in Malaysia
  • Speaker 3:Seiji Tomori
    • Radiological Technologist, Department of Radiology, National Hospital Organization Sendai Medical Center
    • Theme：Clinical Evaluation of AI-VMAT Planning for Head and Neck Cancer: Standardization Based on Dose Prediction AI and Adaptation to Irregular Cases

About AiRato

AiRato is a medical innovation company founded by healthcare professionals and researchers with firsthand experience in cancer treatment. Driven by AI technology, we are committed to transforming the future of cancer care. Starting from real-world challenges in radiation therapy, we develop and deliver medical AI products that are designed for and continuously used in clinical practice.

News